All about COVID-19

Can universal masking be a crude ‘vaccine’?

Known principle: It has been known that that lower inoculums of other viruses, including flu, lead to milder illnesses.   | Photo Credit: Suprabhat Dutta

The idea of allowing people to get naturally infected with novel coronavirus in order to achieve herd immunity even before safe and effective vaccines become available has now been dismissed. Now, a few researchers are putting forth a hypothesis that supports universal mask wearing. According to this hypothesis, universal mask wearing decreases chances of infection, and, if infected, decreases the amount of virus particles (inoculum) a mask-wearer is exposed to thus causing only asymptomatic infection or mild COVID-19 disease.

Dr. Monica Gandhi and Dr. Eric Goosby from the University of California, San Francisco, and Dr. Chris Beyrer from the Johns Hopkins Bloomberg School of Public Health, Baltimore, argue that exposure to the virus “without the unacceptable consequences of severe illness” through universal masking can lead to greater spread of immunity in the community thus slowing down the spread of the virus eventually, even as the world awaits an effective vaccine.

Depending on the type and fit of masks common people use, the amount of virus particles a person is exposed to may be reduced even if infected. According to Dr. Beyrer, cloth masks can screen out between 65% and 85% of viral particles.

Effects of exposure

While much attention has been on the role of masks in reducing or preventing the spread of virus from an infected person to others, the possibility of a healthy mask-wearer getting exposed to only smaller amounts of virus and the possible effects of such exposure has not received equal attention, the researchers write in an article published in the Journal of General Internal Medicine. Dr. Gandhi and Dr. George W. Rutherford from the University of California, San Francisco advance the same idea in a recently published perspective piece in The New England Journal of Medicine.

A growing body of virological, epidemiological, and ecological evidence suggests that universal masking can reduce the severity of disease among people who do become infected, they write. “We have known for more than 50 years that lower inoculums of other viruses, including flu, lead to milder illnesses. Since this is a basic principle in virology, it likely holds true for COVID-19,” Dr. Beyrer told Johns Hopkins.

Learning from studies

In a study of healthy participants exposed to wild-type influenza A virus, more severe symptoms were seen in those exposed to higher amounts of the virus.

A study involving hamsters helped understand the connection between novel coronavirus dose and disease severity. In the study, a surgical mask partition helped reduce the risk of infection in healthy hamsters that were separated from infected ones. And those healthy animals that did get infected had only milder manifestations of infection.

The best epidemiological evidence comes from Diamond Princess cruise ship and a ship in Argentina. While only 18% of passengers in the Diamond Princess cruise ship were asymptomatic, universal masking in the Argentina ship resulted in 81% (128 of 217 passengers and staff) of the infected remaining asymptomatic.

In a seafood processing plant in Oregon, U.S. universal masking could not completely prevent infection, but among the 124 who were infected, 95% were asymptomatic. Similarly, in a Tyson chicken plant in Arkansas, masking resulted in 95% asymptomatic rate of infection. Ecological evidence comes from many Southeast Asian countries that had adopted universal masking from the beginning of the pandemic, reporting fewer cases and deaths.

“If this theory bears out, population-wide masking, might contribute to increasing the proportion of SARS-CoV-2 infections that are asymptomatic,” they write in The New England Journal of Medicine. Since universal masking decreases viral inoculum leading to increase in asymptomatic infection that induces strong T cell immunity for some duration, “could masking be a crude vaccine until we get to a real vaccine?” Dr. Gandhi asks in a tweet.

While a few studies have shown that immune responses are seen in asymptomatically infected individuals, the differences in the duration of protection between asymptomatic and symptomatic infection are not known yet.

Not to misinterpret

It is important that people do not misinterpret the hypothesis to think that one can intentionally inoculate oneself with the virus by wearing a mask. Since studies have not been conducted with the sole purpose of studying the effects of universal masking on COVID-19 severity through reduced virus inoculum, people who wear masks should not become complacent nor should people think that masks are useless as they cannot completely prevent infection in some individuals.

“I am not suggesting pox parties. Just saying masking could be good on multiple levels — decrease transmission, decrease disease severity, help drive up immunity,” Dr. Gandhi tweeted.


Our code of editorial values

This article is closed for comments.
Please Email the Editor

Printable version | Nov 27, 2021 11:05:14 AM | https://www.thehindu.com/sci-tech/science/can-universal-masking-be-a-crude-vaccine/article32588813.ece

In This Package
The Hindu Explains | How is India preparing to roll out COVID-19 vaccines?
The Hindu Explains | Why was a COVID-19 vaccine dry run necessary, and how was it organised?
Coronavirus | Why people with prior infection still need COVID-19 vaccination
Explained | What we know about China-made vaccines
How infections among participants are a part of vaccine trials | The Hindu In Focus podcast
The Hindu Explains | What is emergency use authorisation for drugs and vaccines?
Coronavirus | How the new variant quickly accumulated 23 mutations
Coronavirus | New variant does not increase reinfection risk, disease severity, deaths
Coronavirus | N501Y mutation in SARS-CoV-2 virus causes increased infectivity in mice: researchers
The Hindu Explains | Are viruses expected to change form, and will vaccines protect against a mutating SARS-CoV-2?
Coronavirus | Is the first wave coming to an end in India?
Has India passed the COVID-19 peak? | The Hindu Parley podcast
Has India passed its COVID-19 peak, as a new government study claims? | The Hindu In Focus podcast
No evidence to suggest coronavirus cluster 5 variant found in minks increases virus transmissibility, disease severity
SARS-CoV-2 not the last virus to spark a pandemic, says expert
The Hindu Explains | Who are the top contenders in the race for a COVID-19 vaccine?
The vaccine networks India will rely on and the challenges ahead | The Hindu In Focus podcast
Study advances use of indomethacin for treatment of mild cases
How an asymptomatic player turned super-spreader
How close are we to getting a COVID-19 vaccine? | The Hindu In Focus podcast
WHO warns against pursuing herd immunity to stop coronavirus
Studies document in-flight transmission of coronavirus
Experimental study finds how coronavirus can spread while speaking
You are reading
Can universal masking be a crude ‘vaccine’?
The Hindu Explains | Is COVID-19 setting off a bradykinin storm in the body?
Coronavirus | Lung damage in COVID-19 dead may shed light on ‘long COVID’: study
The Hindu Explains | What does herd immunity mean for COVID-19?
The Hindu Explains | What do we know about Russia’s COVID-19 vaccine candidate Sputnik V?
Coronavirus | Russian vaccine generated strong immune response, says Lancet study
Watch | Is COVID-19 intensifying in rural India?
The Hindu Explains | Why is Phase-3 of COVID-19 vaccine trial complicated?
The Hindu Explains | What are the long-term effects of COVID-19?
The Hindu Explains | Are there re-infection fears around COVID-19?
Watch | COVID-19 and children
The Hindu Explains | Is SARS-CoV-2 a latent virus which can recur?
Watch | What is an immunity passport?
WHO says COVID-19 by far its worst global health emergency
CDC says revised guidance on coronavirus spread posted in error, removes it
Coronavirus | Plasma therapy may look promising in treating COVID-19, but it is no magic bullet
Coronavirus | Different kinds of SARS-CoV-2 exist in India but none more lethal than the other: Indian Academy of Sciences President
The Hindu Explains | Is airborne transmission of COVID-19 a risk?
Watch | What are serological surveys?
The Hindu Explains | Why is a psoriasis drug being used to treat COVID-19 patients?
Video: In conversation with Andrew Pollard, Director of Oxford Vaccine Group
Watch | All you need to know about pulse oximeters
Coronavirus | Why are only a fraction of cases tested?
Coronavirus | Vaccine was rapidly synthesised as novel coronavirus sequence was available, says virologist Gagandeep Kang
A step closer to developing a potent drug against novel coronavirus
Coronavirus | The importance of ‘contact tracing’
Coronavirus | Are diabetics more prone to COVID-19?
Private firms ready to test for COVID-19
Coronavirus | How does soap use help in tackling COVID-19?
Fight for the finite: On budgetary allocation for health
Coronavirus | A problematic testing strategy
Fighting COVID-19 together for a shared future
Scientists get ready to test rival COVID-19 pandemic vaccines in animals
Coronavirus | The cost of opacity
Watch | COVID-19: Masks and sanitisers are now essential commodities
A COVID-19 control plan made simple
Watch | Your COVID-19 queries answered
Coronavirus | How is India containing COVID-19?
Battle against COVID-19
Watch | COVID-19: Dos and don'ts from the Health Ministry
A COVID-19 response that is quick off the blocks
Watch | Why is COVID-19 not a pandemic yet?
Watch | Coronavirus: Can masks protect you?
Watch | How is India dealing with coronavirus?
WHO’s unexplained hesitancy
Watch | Bats and the novel coronavirus
Coronavirus | India shares two SARS-CoV-2 genome sequences
COVID-19 | We are in uncharted territory, says WHO
Explained | Why is COVID-19 not a pandemic yet?
New COVID-19 epidemic at ‘decisive point’: WHO chief
COVID-19 vaccine may be ready by 2022: SII
Explainer: How WHO names a new disease
WHO names deadly viral disease from China as 'COVID-19'
Explained | When can people transmit the novel coronavirus?
Analysis | For China’s Xi, the coronavirus challenge comes laden with economic costs and political risks
How bats harbour several viruses yet not get sick
WHO declares coronavirus outbreak a global emergency
Watch | What is Coronavirus?
What is the source of the new SARS-like disease reported in China?
Data | The wide, rapid spread of the novel coronavirus
Alarming spread: on novel coronavirus outbreak
Gaps in our knowledge of coronavirus origin need fulfilment: Study
A new virus emerges in China
Next Story